Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2021-11-22 00:00:00 ET · period of report 2021-11-18 · accession 0001062993-21-011406 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-22 | 2021-11-18 | ORGO | Albert Erani Family Trust dated 12/29/2012 | 10% | P - Purchase | $9.93 | +25.0K | 59.45M | +0.0% | +$248.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-11-18 | P | A | 25,000 | $9.93 | 59,448,027 | D | — | — | (F1) The reported securities were purchased and held directly by Glenn H. Nussdorf, who is a member of the Group (as defined below). (F2) The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $9.89 to $9.95, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. (F3) Reflects the total number of securities held by the Group. |